Schellekens PT - Search Results

1

Appearance of predictors of disease progression in relation to the development of AIDS.

de Wolf F, Lange JM, Houweling JT, Mulder JW, Beemster J, Schellekens PT, Coutinho RA, van der Noordaa J, Goudsmit J. de Wolf F, et al. Among authors: schellekens pt. AIDS. 1989 Sep;3(9):563-9. doi: 10.1097/00002030-198909000-00002. AIDS. 1989. PMID: 2571348

2

Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.

de Wolf F, Goudsmit J, Paul DA, Lange JM, Hooijkaas C, Schellekens P, Coutinho RA, van der Noordaa J. de Wolf F, et al. Br Med J (Clin Res Ed). 1987 Sep 5;295(6598):569-72. doi: 10.1136/bmj.295.6598.569. Br Med J (Clin Res Ed). 1987. PMID: 3117235 Free PMC article.

3

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

Schellekens PT, Tersmette M, Roos MT, Keet RP, de Wolf F, Coutinho RA, Miedema F. Schellekens PT, et al. AIDS. 1992 Jul;6(7):665-9. doi: 10.1097/00002030-199207000-00008. AIDS. 1992. PMID: 1354447

4

Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.

Gruters RA, Terpstra FG, Lange JM, Roos MT, Harkema T, Mulder JW, De Wolf F, Schellekens PT, Miedema F. Gruters RA, et al. Among authors: schellekens pt. AIDS. 1991 Jan;5(1):43-7. doi: 10.1097/00002030-199101000-00006. AIDS. 1991. PMID: 1676272

5

Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.

Mientjes GH, Miedema F, van Ameijden EJ, van den Hoek AA, Schellekens PT, Roos MT, Coutinho RA. Mientjes GH, et al. Among authors: schellekens pt. AIDS. 1991 Jan;5(1):35-41. doi: 10.1097/00002030-199101000-00005. AIDS. 1991. PMID: 1829366

6

Immunological and virological markers in individuals progressing from seroconversion to AIDS.

Gruters RA, Terpstra FG, De Goede RE, Mulder JW, De Wolf F, Schellekens PT, Van Lier RA, Tersmette M, Miedema F. Gruters RA, et al. Among authors: schellekens pt. AIDS. 1991 Jul;5(7):837-44. doi: 10.1097/00002030-199107000-00007. AIDS. 1991. PMID: 1892588

7

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.

Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM. Mulder JW, et al. Among authors: schellekens pt. Antiviral Res. 1990 Mar;13(3):127-38. doi: 10.1016/0166-3542(90)90028-6. Antiviral Res. 1990. PMID: 1972321

8

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

Schellekens PT, Roos MT, De Wolf F, Lange JM, Miedema F. Schellekens PT, et al. J Clin Immunol. 1990 Mar;10(2):121-7. doi: 10.1007/BF00918194. J Clin Immunol. 1990. PMID: 2140115

9

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, Schellekens PT, Coutinho RA, Huisman JG, Goudsmit J, Miedema F. Tersmette M, et al. Among authors: schellekens pt. Lancet. 1989 May 6;1(8645):983-5. doi: 10.1016/s0140-6736(89)92628-7. Lancet. 1989. PMID: 2565516

10

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

de Wolf F, Lange JM, Goudsmit J, Cload P, de Gans J, Schellekens PT, Coutinho RA, Fiddian AP, van der Noordaa J. de Wolf F, et al. Among authors: schellekens pt. Lancet. 1988 Feb 20;1(8582):373-6. doi: 10.1016/s0140-6736(88)91179-8. Lancet. 1988. PMID: 2893187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters